Invivoscribe^® is a global, vertically integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics^®. For over thirty years, Invivoscribe has advanced precision medicine by providing high-quality standardized reagents, assays, and bioinformatics tools, while supporting pharmaceutical partners through clinical trials, companion diagnostic development, and global regulatory expertise. With the launch of the PrepQuant System, the Invivoscribe ecosystem now includes instrumentation, extending our standardization efforts beyond diagnostic tests to include the critical pre-analytical steps that ensure accuracy and reproducibility from start to finish. For more information, please visit www.invivoscribe.com, contact inquiry@invivoscribe.com, or follow Invivoscribe on LinkedIn.